القنوات الاخباريه

autism health news    التوحد  

alexdoctor home page
cnn
سى ان ان
bbc
بى بى سى
reuters
رويترز
foxnews
فوكس نيوز
washington post
واشنطن بوست
medical news
مديكال نيوز
abc
اى بى سى

Alzheimer

الزهايمر
autism
التوحد

bird flu

انفلونزا الطيور

breast cancer

سرطان الثدى

cardiovascular

امراض القلب

complementary

الطب البديل
dental
طب الاسنان

diabetes

مرض السكر

dermatology

الامراض الجلديه

ent

انف و اذن و حنجره

epilepsy

الصرع

fertility

الخصوبه
eye
طب العيون

hypertension

ارتفاع ضغط الدم
liver disease
امراض الكبد

men disease

صحه الرجل

pediatric

صحه الطفل

pharmacy

الصيدله

pregnancy

الحمل

respiratory-asthma

حساسيه الصدر

smoking

التدخين

stroke

السكته الدماغيه

women- health

صحه المرأه
nephrology
الكلى و المسالك
Autism News From Medical News Today
Texas Raises Organ Donor Registry; D.C. Not Ready For Medical Marijuana Sales; L.A. Health Department Facing Major Service Cuts
The Houston Chronicle: "Though Texas has the nation's lowest percentage of registered organ and tissue donors, several recent initiatives have more than doubled the state's donor rolls this year. The number enrolled in the Glenda Dawson Donate Life Texas Registry has ballooned since Jan...
New York State Approves Quest Diagnostics' Fragile X Syndrome Test
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism...
Curemark Opens Autism Trials At New Jersey Site
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment. Saint Peter's is affiliated with the Drexel University College of Medicine in Philadelphia...
Autism Charity Raises The Bar For Legal Campaigning, UK
The National Autistic Society (NAS) has ramped up its legal campaigning with the launch of a new Autism Legal Network and a call for cases with the potential to change the law for the half a million people with autism in the UK. Mark Lever, chief executive of the NAS said; "The NAS is evolving. Last year we successfully secured the landmark Autism Act...
Seaside Therapeutics Reports Data From Randomized, Placebo-Controlled Phase 2 Study In Fragile X Syndrome
Seaside Therapeutics, Inc. announced data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population...
Asuragen And Collaborators Report Results Using PCR-Only Technologies For The Comprehensive Molecular Assessment Of The Fragile X Gene
Asuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods...
XenoPort Announces Presentation Of Preclinical Data For Acamprosate Prodrug At Fragile X Syndrome Conference
XenoPort, Inc. (Nasdaq:XNPT) announced that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan...
Leading Researchers To Share New Treatments At Fragile X International Conference
Accelerated research findings leading to potentially significant new treatments for fragile X syndrome (FXS) will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25...
New Survey By Enzymedica Links Autism & Digestion, Suggests Successful Strategies
Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined...
A National Autistic Society Response To The Commission On The Funding Of Care And Support, UK
The National Autistic Society (NAS) has welcomed the establishment of the Commission on the Funding of Care and Support today, but urged that it must consider how to fund support for those with lifelong conditions, such as autism, who are less able to save and pay for their social care...
RSS integration by RSSinclude
autism
  • التوحد يوصف بأنه 
  • اهتمام ضعيف جدا بالمجتمع 
  • مشاكل فى الاتصالات الشفهية وغير الشفهية 
  •  اهتمامات ونشاطات محدوده غير عادية و متكررة
  • التوحد أكثر شيوعا من الطفل المنغولى أو سرطان الأطفال 
  • سوء معامله الآباء او الامهات لأبنائهم لا تسبب التوحد ، إنه مرض عصبى وليس نفسى  
  • باتفاق دراستان كبيرتان ، لا يوجد علاقة بين التطعيم و التوحد
 إشارات تنبه بأن هذا الطفل قد يكون متوحدا 
  • لا يوجد ابتسامة كبيرة فى خلال ستة أشهر من بعد ولادته
  • . لا يحاول الثرثرة أو الهدهدة حتى عامه الاول
  • . لا يشير أو لا يلوح حتى عامه الاول
  •  لا يتكلم كلمة واحدة عند عمر 16 شهر
  •  لا يتكلم كلمتين تكونان عبارة فى عمر سنتين 
  •  لا يوجد خبرات فى اللغة أو المهارات الاجتماعية فى أى سن .
  •  تجنب النظر الى العين
  •  أداء تكرارى للحركات ، مثل الاهتزاز ، السقوط .و الدوران

اختبر معلوماتك عن الطفل المتوحد

استشارات المخ و الأعصاب و الطب النفسى , للأستاذ الدكتور عبد الفتاح القرش


المعلوما ت الطبيه للثقافه الطبيه و لا تغنى عن استشاره الطبيب
تمت مراجعه هذا الجزء بواسطه دكتور اسامه الحصيوى
شروط استخدام الموقع و سياسه الخصوصيه
اخر تحديث بتاريخ 25 يونيو 2008